Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.53 CAD | +2.00% | +6.99% | -14.53% |
04-11 | Oncolytics Biotech Inc. Announces the Submission of a Type C Meeting Request to the FDA | CI |
04-11 | Oncolytics Biotech Down 1.8% In US Premarket As Submits Type C Meeting Request to FDA | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.53% | 82.88M | |
+0.17% | 42.86B | |
+10.92% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.23% | 25.15B | |
-24.79% | 18.63B | |
+26.69% | 12.37B | |
-3.13% | 11.92B | |
+6.57% | 11.21B |
- Stock Market
- Equities
- ONC Stock
- News Oncolytics Biotech Inc.
- RBC Capital on Takeaways From Oncolytics' KOL Call on Pancreatic Cancer, Updated Interim Ph 1/2 GOBLET Study Data